Results from a Phase III clinical trial published in the New England Journal of Medicine, show that patients with lung cancer ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

Results from a phase 3 clinical trial published in the New England Journal of Medicine, today (June 2nd) show that patients ...

The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease progressing or death.

The purpose of this article is to present the historic and current trends of tobacco use as relates to lung cancer, discuss the effects of tobacco on outcomes in patients with lung cancer, discuss the ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

A randomized phase II trial of oral vinorelbine as second-line therapy for patients with malignant pleural mesothelioma.